Women’s health practices face growing pressure to deliver personalized care while operating under reimbursement constraints and staffing shortages. A January 2026 report from the World Economic Forum found that women’s health has captured just 6% of private healthcare investment despite women making up nearly half the global population. Nearly 90% of that capital is concentrated in reproductive health, maternal care, and oncology. However, investment in operational infrastructure — intake, scheduling, and payment workflows — remains largely overlooked.
The solution lies in moving high-value work upstream, according to industry leaders. Collecting medication lists, obstetric history, screening questionnaires, and consents before appointments transforms registration from reactive scramble into predictable, auditable workflow. When pre-visit intake feeds clean, coded data into the medical record, clinicians begin visits with context rather than catch-up, improving safety, efficiency, and revenue capture.
Prenatal care demonstrates the approach’s effectiveness. The prenatal schedule includes dense predetermined screening points: first-trimester labs, genetic screening conversations, glucose testing, vaccine counseling, and growth monitoring. Automated intake ensures patients complete required forms, validate insurance, and capture consent before each visit, allowing required labs to be ordered on time and staff to prioritize patients needing immediate intervention.
Insurance verification deserves emphasis. Real-time eligibility checks built into pre-visit workflows reduce collection scrambles and speed time-to-cash. For women’s health clinics juggling private, Medicaid, and self-pay patients, clarity about coverage before the visit avoids checkout complications and minimizes bad debt. Phone volume is another area where practices bleed time. Automating predictable transactions like confirming availability and completing scheduling allows front-desk staff to focus on patients needing human interaction.
Equity must be designed in from the start. Digital intake tools should be mobile-first, available in multiple languages, and offer assisted entry for patients preferring phone or in-clinic help. PitchBook reported that femtech venture capital deal value surpassed $5 billion since 2020, with $1.2 billion raised in 2024 alone. The Gates Foundation committed $2.5 billion through 2030 to women’s health R&D.
This article is an AI-assisted summary. All facts and figures are drawn from the original report: https://medcitynews.com/2026/05/reducing-admin-waste-in-womens-health-the-financial-case-for-upstream-workflows/